271. 強直性脊椎炎 Ankylosing spondylitis Clinical trials / Disease details

臨床試験数 : 563 / 薬物数 : 372 - (DrugBank : 72) / 標的遺伝子数 : 41 - 標的パスウェイ数 : 145

3 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03473665 (ClinicalTrials.gov)	March 1, 2018	13/3/2018	Non-Steroidal Anti-inflammatory Drugs in Axial Spondyloarthritis	Non-Steroidal Anti-inflammatory Drugs in Axial Spondyloarthritis: a Pilot Study	Ankylosing Spondylitis;Axial Spondyloarthritis	Drug: Indomethacin;Drug: Diclofenac;Drug: Meloxicam;Drug: Celecoxib	Columbia University	NULL	Terminated	18 Years	N/A	All	9	Phase 4	United States
2	NCT04480359 (ClinicalTrials.gov)	October 1, 2017	16/7/2020	Bawei Shenqi Pill in the Treatment of Ankylosing Spondylitis	The Clinical Research of the Traditional Chinese Medicine Bawei Shenqi Pill in the Treatment of the Kidney Yang Deficiency Type of Ankylosing Spondylitis	Ankylosing Spondylitis	Drug: Bawei Shenqi Pill;Drug: Bawei Shenqi Pill placebo;Drug: Meloxicam	Shanghai University of Traditional Chinese Medicine	NULL	Recruiting	18 Years	70 Years	All	80	Phase 2/Phase 3	China
3	NCT02183168 (ClinicalTrials.gov)	July 2001	4/7/2014	Evaluation of Efficacy and Safety of Meloxicam Suppository (15mg Daily) and Tablet (15 mg Daily) Compared to Indomethacin Suppository (50 mg Daily) in Patients With Ankylosing Spondylitis	A Randomized, Open Label, 3-arm Evaluation of Efficacy and Safety of Meloxicam Suppository (15mg Daily) and Tablet (15 mg Daily) Compared to Indomethacin Suppository (50 mg Daily) in Patients With Ankylosing Spondylitis	Spondylitis, Ankylosing	Drug: Meloxicam suppository;Drug: Meloxicam tablet;Drug: Indomethacin	Boehringer Ingelheim	NULL	Completed	N/A	N/A	Both	192	Phase 3	NULL